| Ytd | 28.30% | |
| 1y | -42.37% |
| Open | 1.39 | Prev Close | 1.39 | Low | 1.36 | High | 1.40 | Mkt Cap | 7.47M |
| Vol | 11.24K | Avg Vol | 941.47K | EPS | -2.84 | P/E | N/A | Forward P/E | -0.75 |
| Beta | 0.71 | Short Ratio | 0.12 | Inst. Own | 8.96% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-05 | 50-d Avg | 1.47 | 200-d Avg | 1.18 | 1yr Est | 20.00 |
INM News
Vancouver, British Columbia--(Newsfile Corp. - September 18, 2026) - InMed Pharmaceuticals Inc. (NAS
Vancouver, British Columbia--(Newsfile Corp. - September 9, 2026) - InMed Pharmaceuticals Inc. (NASD
InMed Pharmaceuticals (NASDAQ: INM - Get Free Report) and Reviva Pharmaceuticals (NASDAQ: RVPH - Get
Mentari Therapeutics, a privately held biotechnology enterprise dedicated to preventing migraines, h
Mentari Therapeutics secures $200 million in private financing before merging with InMed Pharmaceuti
Gainers Advanced Biomed (NASDAQ:ADVB) shares moved upwards by 108.6% to $14.77 during Wednesday'
Gainers InMed Pharmaceuticals (NASDAQ:INM) stock moved upwards by 66.8% to $2.57 during Wednesday&#
WALTHAM, Mass., July 22, 2026 /PRNewswire/ -- Mentari Therapeutics, Inc. ("Mentari"), a privately-he
Artisan Mid Cap Fund portfolio generated strong absolute returns and outpaced the Russell Midcap® Gr
Gainers Q32 Bio (NASDAQ:QTTB) stock moved upwards by 44.4% to $16.19 during Friday's after-mark
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following compan
Vancouver, British Columbia and San Francisco, California--(Newsfile Corp. - July 6, 2026) - InMed P
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following compan
Vancouver, British Columbia--(Newsfile Corp. - June 4, 2026) - InMed Pharmaceuticals Inc. (NASDAQ: I
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following compan
SHAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--RAMP, NEE, D, and
NEW YORK, May 27, 2026 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde &
InMed Pharmaceuticals Inc. (INM) M&A Call Prepared Remarks Transcript
NEW YORK, May 20, 2026 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & A
BALA CYNWYD, Pa., May 19, 2026 (GLOBE NEWSWIRE) -- Law office of Brodsky & Smith announces that it i
/C O R R E C T I O N -- InMed Pharmaceuticals/ PR Newswire VANCOUVER, BC and SAN FRANCISCO, May 19,
US stocks down, Nasdaq drops 200 points. Dow -0.35% at 49,512.48, Nasdaq -0.93% at 25,849.08, S&
Halper Sadeh LLC, an investor rights law firm, is investigating the merger of InMed Pharmaceuticals,
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the merge
US stocks fall, Dow Jones down 0.34% & NASDAQ down 0.41% in morning trading. Home Depot reports
InMed Pharmaceuticals Inc. (NASDAQ:INM) shares are up during Tuesday's premarket session, as the com
Qualcomm shares rose 10.6% in pre-market trading after reporting better-than-expected Q2 results. Ot
AI-related stocks including industry leaders like Nvidia (NASDAQ: NVDA), cloud computing, and cybers
U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining over 200 point
Gainers InMed Pharmaceuticals Inc. (NASDAQ: INM) shares climbed 169% to $1.56 after the company a
U.S. stocks traded slightly higher midway through trading, with the Dow Jones index gaining around 5
On Wednesday, 311 stocks hit new 52-week lows.
On Tuesday, 386 stocks made new 52-week lows.
Wednesday's session saw 150 companies set new 52-week lows.
On Tuesday, 210 companies reached new 52-week lows.
GAINERS: Red White & Bloom Brands (OTC: RWBYF) shares closed up 300.00% at $0.04
During Monday's session, 201 stocks hit new 52-week lows.
Gainers Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE) shares climbed 422% to $0.5572 after the comp
Tuesday's session saw 325 companies set new 52-week lows.
OnFriday, 143 stocks hit new 52-week lows.